Mezei Zoltán András

1.

Guba, A., Kováts, P., Mezei, Z. A., Papp, M., Csősz, É., Kalló, G.: Analysis of Azathioprine Metabolites in Autoimmune Hepatitis Patient Blood-Method Development and Validation.
Int. J. Mol. Sci. 25 (20), 1-12, (article identifier: 11233), 2024.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis (2023)

Q1 Computer Science Applications (2023)

D1 Inorganic Chemistry (2023)

Q1 Medicine (miscellaneous) (2023)

Q2 Molecular Biology (2023)

D1 Organic Chemistry (2023)

Q1 Physical and Theoretical Chemistry (2023)

D1 Spectroscopy (2023)

2.

Baráth, S., Singh, P., Hevessy, Z., Ujfalusi, A., Mezei, Z. A., Balogh, M., Széles, M., Kappelmayer, J.: Enhancing HLA-B27 antigen detection: Leveraging machine learning algorithms for flow cytometric analysis.
Cytom. Part B-Clin. Cytom. [Epub ahead of print], 2024.

doi DEA WoS Scopus

Journal metrics:

Q3 Cell Biology (2023)

Q2 Histology (2023)

Q1 Pathology and Forensic Medicine (2023)

3.

Pethő, Á. G., Nagy, Z., Mezei, Z. A., Takács, I., Demeter, J.: Béta-thalassaemia, B12-vitamin-hiány és társuló komplementmediált hemolízis.
Orv. hetil. 164 (24), 954-960, 2023.

doi DEA Scopus

Journal metrics:

Q4 Medicine (miscellaneous)

4.

Singh, P., Széles, M., Mezei, Z. A., Baráth, S., Hevessy, Z.: Age-dependent frequency of unconventional T cells in a healthy adult Caucasian population: a combinational study of invariant natural killer T cells, [gamma][delta] T cells, and mucosa-associated invariant T cells.
GeroScience. 44 (4), 2047-2060, 2022.

doi DEA WoS Scopus

Journal metrics:

Q1 Aging

Q1 Cardiology and Cardiovascular Medicine

D1 Complementary and Alternative Medicine

Q1 Geriatrics and Gerontology

D1 Veterinary (miscellaneous)

5.

Baráth, S., Mezei, Z. A., Széles, M., Hevessy, Z.: Combined use of different antibody clones improves the efficiency of human leukocyte antigen B27 detection by flow cytometry.
Cytom. Part B-Clin. Cytom. 102 (3), 239-245, 2022.

doi DEA WoS Scopus

Journal metrics:

Q2 Cell Biology

Q1 Histology

Q1 Pathology and Forensic Medicine

6.

Singh, P., Széles, M., Mezei, Z. A., Baráth, S., Hevessy, Z.: Gender-dependent frequency of unconventional T cells in a healthy adult Caucasian population: a combinational study of invariant NKT cells, [gamma] [delta] T cells, and mucosa-associated invariant T cells.
J. Leukoc. Biol. 112 (5), 1155-1165, 2022.

doi DEA WoS Scopus

Journal metrics:

Q1 Cell Biology

Q1 Immunology

Q1 Immunology and Allergy

7.

Bereczky, Z., Gindele, R., Fiatal, S., Speker, M., Miklós, T., Balogh, L., Mezei, Z. A., Szabó, Z., Ádány, R.: Age and Origin of the Founder Antithrombin Budapest 3 (p.Leu131Phe) Mutation; Its High Prevalence in the Roma Population and Its Association With Cardiovascular Diseases.
Front. Cardiovasc. Med. 7, 1-15, 2021.

doi DEA

Journal metrics:

Q1 Cardiology and Cardiovascular Medicine

8.

Koczok, K., Horváth, L., Korade, Z., Mezei, Z. A., P. Szabó, G., Porter, N. A., Kovács, E., Mirnics, K., Balogh, I.: Biochemical and Clinical Effects of Vitamin E Supplementation in Hungarian Smith-Lemli-Opitz Syndrome Patients.
Biomolecules. 11 (8), 1-11, 2021.

doi DEA WoS Scopus

Journal metrics:

Q2 Biochemistry

Q2 Molecular Biology

9.

Szántó, K., Mezei, Z. A., Kata, D., Földesi, I., Nyári, T., Fábián, A., Rutka, M., Bor, R., Bálint, A., Milassin, Á., Szepes, Z., Nagy, F., Palatka, K., Farkas, K., Molnár, T.: Combination therapy with anti-TNFs and thiopurines does affect drug metabolite levels but it is not associated with body composition in inflammatory bowel disease patients: a cross-sectional study.
Gasztroenterol. Hepatol. Szle. 7 (4), 164-170, 2021.

doi DEA

10.

Baráth, B., Kissné Bogáti, R., Miklós, T., Kállai, J., Mezei, Z. A., Bereczky, Z., Muszbek, L., Katona, É.: Effect of [alfa]2-plasmin inhibitor heterogeneity on the risk of venous thromboembolism.
Thromb. Res. 203, 110-116, 2021.

doi DEA WoS Scopus

Journal metrics:

Q1 Hematology

11.

Mezei, Z. A., Tornai, D., Földesi, R., Madar, L., Sümegi, A., Papp, M., Antal-Szalmás, P.: A DNA pool of FLT3-ITD positive DNA samples can be used efficiently for analytical evaluation of NGS-based FLT3-ITD quantitation: testing several different ITD sequences and rates, simultaneously.
J. Biotechnol. 303, 25-29, 2019.

doi DEA WoS Scopus

Journal metrics:

Q1 Applied Microbiology and Biotechnology

Q2 Bioengineering

Q1 Biotechnology

Q1 Medicine (miscellaneous)

12.

Szántó, K., Szíjártó, A., Kata, D., Földesi, I., Mezei, Z. A., Fábián, Á. I., Bálint, A., Bor, R., Farkas, K., Milassin, Á., Rutka, M., Szepes, Z., Nagy, F., Bubán, T., Lovas, S., Palatka, K., Molnár, T.: Blood thiopurine level, anti-TNF drug level and body composition parameters in inflammatory bowel diseases patients: a cross-sectional study in a Hungarian IBD centre.
J. Crohns Colitis. 13 (Supplement1), S456, 2019.

doi DEA WoS

13.

Katona, É., Kissné Bogáti, R., Miklós, T., Gindele, R., Speker, M., Fedoriska, V., Orosz, A., Mezei, Z. A., Bereczky, Z.: ALPHA-2 Plasmin Inhibitor Activity and Antigen Levels and p.Arg6Trp Polymorphism in Patients with Venous Thromboembolism.
Proceedings. 2 (9), 102-103, 2018.

doi DEA

14.

Balogh, L., Katona, É., Mezei, Z. A., Kállai, J., Gindele, R., Édes, I., Muszbek, L., Papp, Z., Bereczky, Z.: Effect of factor XIII levels and polymorphisms on the risk of myocardial infarction in young patients.
Mol. Cell. Biochem. 448 (1-2), 199-209, 2018.

doi DEA

Journal metrics:

Q3 Cell Biology

Q2 Clinical Biochemistry

Q1 Medicine (miscellaneous)

Q3 Molecular Biology

15.

Székely, E. G., Czuriga-Kovács, K. R., Bereczky, Z., Katona, É., Mezei, Z. A., Nagy, A. C., Tóth, N. K., Berényi, E., Muszbek, L., Csiba, L., Bagoly, Z.: Low factor XIII levels after intravenous thrombolysis predict short-term mortality in ischemic stroke patients.
Sci. Rep. 8 (1), 1-9, 2018.

doi DEA WoS Scopus

Journal metrics:

D1 Multidisciplinary

16.

Gindele, R., Colombo, R., Szabó, Z., Speker, M., Mezei, Z. A., Balogh, L., Katona, É., Bagoly, Z., Fiatal, S., Bereczky, Z.: Prevalence of Antithrombin Budapest 3 Mutation among Different Patients Groups; Investigation of the Age and Origin of Mutation Common in Hungary.
Proceedings. 2 (9), 76-77, 2018.

doi DEA

17.

Kurdi, B., Mezei, Z. A., Kellner, Á., Egyed, M.: Thalassaemiás betegen észlelt anaemia perniciosa: a diagnózis nehézségei.
Orv. hetil. 159 (33), 1368-1371, 2018.

doi DEA WoS Scopus

Journal metrics:

Q3 Medicine (miscellaneous)

18.

Katona, É., Kissné Bogáti, R., Miklós, T., Gindele, R., Speker, M., Fedoriska, V., Orosz, A., Mezei, Z. A., Bereczky, Z.: The Effect of Alpha-2 Plasmin Inhibitor Activity and Antigen Levels and p.Arg6Trp Polymorphism on the Risk of Venous Thromboembolism.
Res Pract Thromb Haemost. 2, 324-324, 2018.

doi DEA

19.

Mádi, A., Cuaranta-Monroy, I., Lénárt, K., Pap, A., Mezei, Z. A., Kristóf, E., Oláh, A., Vámosi, G., Bacsó, Z., Bai, P., Fésüs, L.: Browning deficiency and low mobilization of fatty acids in gonadal white adipose tissue leads to decreased cold-tolerance of transglutaminase 2 knock-out mice.
Biochim. Biophys. Acta. Mol. Cell Biol. Lipids. 1862 (12), 1575-1586, 2017.

doi DEA

Journal metrics:

Q1 Cell Biology

Q1 Molecular Biology

20.

Mezei, Z. A., Katona, É., Kállai, J., Bereczky, Z., Somodi, L., Molnár, É., Kovács, B., Miklós, T., Ajzner, É., Muszbek, L.: Factor XIII levels and factor XIII B subunit polymorphisms in patients with venous thromboembolism.
Thromb. Res. 158, 93-97, 2017.

DEA WoS Scopus

Journal metrics:

Q2 Hematology

21.

Mezei, Z. A., Katona, É., Kállai, J., Bereczky, Z., Molnár, É., Kovács, B., Ajzner, É., Bagoly, Z., Miklós, T., Muszbek, L.: Regulation of plasma factor XIII levels in healthy individuals; a major impact by subunit B intron K c.1952+144 C>G polymorphism.
Thromb. Res. 148, 101-106, 2016.

doi DEA WoS Scopus

Journal metrics:

Q2 Hematology

22.

Mezei, Z. A., Bereczky, Z., Katona, É., Gindele, R., Balogh, E., Fiatal, S., Balogh, L., Czuriga, I., Ádány, R., Édes, I., Muszbek, L.: Factor XIII B Subunit Polymorphisms and the Risk of Coronary Artery Disease.
Int. J. Mol. Sci. 16 (1), 1143-1159, 2015.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

Q1 Computer Science Applications

Q1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

Q1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

Q1 Spectroscopy

23.

Shemirani, A. H., Antalfi, B., Pongrácz, E., Mezei, Z. A., Bereczky, Z., Csiki, Z.: Factor XIII-A subunit Val34Leu polymorphism in fatal atherothrombotic ischemic stroke.
Blood Coagul. Fibrinolysis. 25 (4), 364-368, 2014.

doi DEA

Journal metrics:

Q3 Hematology

Q2 Medicine (miscellaneous)

24.

Antalfi, B., Pongrácz, E., Csiki, Z., Mezei, Z. A., Shemirani, A. H.: Factor XIII-A subunit Val34Leu polymorphism in fatal hemorrhagic stroke.
Int. J. Lab. Hematol. 35 (1), 88-91, 2013.

doi DEA

Journal metrics:

Q2 Endocrinology

Q2 Endocrinology, Diabetes and Metabolism

Q1 Medicine (miscellaneous)

Q2 Orthopedics and Sports Medicine

25.

Bagoly, Z., Székely, E. G., Kovács, K. R., Mezei, Z. A., Katona, É., Kappelmayer, J., Csiba, L., Muszbek, L.: The effect of factor XIII and other regulators of fibrinolysis on the outcome of thrombolysis in ischemic stroke patients.
J. Thromb. Haemost. 11 (s2), 405-406, 2013.

DEA

Mezei Zoltán András

Publication list